News
Feb 01, 2026

IND Approval for PN-101 by MFDS

IND Approval for PN-101 by MFDS
IND Approval for PN-101 by MFDS

Source

Source: https://biz.chosun.com/stock/stock_general/2021/06/17/Y2ICBHE75RHZTN3XCFO3LXGUVE/
33 views
Share:

Related News

More Updates From Our Research Journey

News Paean Bio "Developing mitochondrial treatments for rare diseases and cancer... Full-scale clinical trials next year"

Paean Bio "Developing mitochondrial treatments for rare diseases and cancer... Full-scale clinical trials next year"

Feb 04, 2026

Paean Bio "Developing mitochondrial treatments for rare diseases and cancer... F...

Read More
News [Live Report] Bio companies including BiocurePharm and Paean gather... Fierce technology competition

[Live Report] Bio companies including BiocurePharm and Paean gather... Fierce technology competition

Feb 04, 2026

[Live Report] Bio companies including BiocurePharm and Paean gather... Fierce te...

Read More
News Paean Bio Targets Autoimmune and Tumor with 'MT Transplant Platform'

Paean Bio Targets Autoimmune and Tumor with 'MT Transplant Platform'

Feb 04, 2026

Paean Bio Targets Autoimmune and Tumor with 'MT Transplant Platform'

Read More
News [Promising Company] Paean Biotechnology embarks on world's first mitochondrial clinical trial

[Promising Company] Paean Biotechnology embarks on world's first mitochondrial clinical trial

Feb 01, 2026

[Promising Company] Paean Biotechnology embarks on world's first mitochondrial c...

Read More
Logo

Headquarter : 108SB, DaeduckBiz Center
17 Techno 4-ro, Yuseong-gu, Daejeon 34013, Korea

Mail : info@paeanbio.com

Phone : 042-334-7378 | Fax : 042-334-7096

Navigation

Other

Copyrights © 2025 All Rights Reserved by PAEAN BIOTECHNOLOGY